Skip to main content

Table 1 The 29 genes identified in our previous genetic interaction study on bladder cancer using SEN

From: Functional genomics annotation of a statistical epistasis network associated with bladder cancer susceptibility

Symbol

Entrez Gene ID

Description

AHRR

57491

Aryl-hydrocarbon receptor repressor

AKR1C3

8644

Aldo-keto reductase family 1, member C3

AXIN2

8313

Axin2

BCL6

604

B-cell CLL/lymphoma 6

BIRC3

330

Baculoviral IAP repeat containing 3

CARD15

64127

Nucleotide-binding oligomerization domain containing 2

CAT

847

Catalase

CCL5

6352

Chemokine (C-C motif) ligand 5

CCNH

902

Cyclin H

FTHFD

10840

Aldehyde dehydrogenase 1 family, member L1

GATA3

2625

GATA binding protein 3

GSTM3

2947

Glutathione S-transferase mu 3 (brain)

HSD17B4

3295

Hydroxysteroid (17-beta) dehydrogenase 4

IGF1R

3480

Insulin-like growth factor 1 receptor

IL1A

3552

Interleukin 1, alpha

INSR

3643

Insulin receptor

MASP1

5648

Mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor)

MBD2

8932

Methyl-CpG binding domain protein 2

MMP1

4312

Matrix metallopeptidase 1 (interstitial collagenase)

MYBL2

4605

V-myb myeloblastosis viral oncogene homolog (avian)-like 2

NEDD5

4735

Septin 2

OPRM1

4988

Opioid receptor, mu 1

PARP4

143

Poly (ADP-ribose) polymerase family, member 4

PGR

5241

Progesterone receptor

PIM1

5292

Pim-1 oncogene

RERG

85004

RAS-like, estrogen-regulated, growth inhibitor

TNKS

8658

Tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase

TP53I3

9540

Tumor protein p53 inducible protein 3

XPC

7508

Xeroderma pigmentosum, complementation group C